- Home
- SRTS vs OMGA Comparison
SRTS vs OMGA Comparison
Compare SRTS & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- OMGA
- Stock Information
- Founded
- SRTS 2010
- OMGA 2017
- Country
- SRTS United States
- OMGA United States
- Employees
- SRTS N/A
- OMGA N/A
- Industry
- SRTS Medical/Dental Instruments
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- SRTS Health Care
- OMGA Health Care
- Exchange
- SRTS Nasdaq
- OMGA Nasdaq
- Market Cap
- SRTS 118.2M
- OMGA 53.6M
- IPO Year
- SRTS 2016
- OMGA 2021
- Fundamental
- Price
- SRTS $6.64
- OMGA $0.60
- Analyst Decision
- SRTS Strong Buy
- OMGA Strong Buy
- Analyst Count
- SRTS 2
- OMGA 5
- Target Price
- SRTS $12.50
- OMGA $9.20
- AVG Volume (30 Days)
- SRTS 244.3K
- OMGA 276.0K
- Earning Date
- SRTS 02-06-2025
- OMGA 11-14-2024
- Dividend Yield
- SRTS N/A
- OMGA N/A
- EPS Growth
- SRTS N/A
- OMGA N/A
- EPS
- SRTS 0.57
- OMGA N/A
- Revenue
- SRTS $41,308,000.00
- OMGA $8,095,000.00
- Revenue This Year
- SRTS $65.04
- OMGA $181.38
- Revenue Next Year
- SRTS $24.87
- OMGA N/A
- P/E Ratio
- SRTS $11.51
- OMGA N/A
- Revenue Growth
- SRTS 65.62
- OMGA 185.04
- 52 Week Low
- SRTS $2.61
- OMGA $0.58
- 52 Week High
- SRTS $9.33
- OMGA $4.46
- Technical
- Relative Strength Index (RSI)
- SRTS 37.42
- OMGA 30.33
- Support Level
- SRTS $6.38
- OMGA $0.74
- Resistance Level
- SRTS $7.62
- OMGA $0.80
- Average True Range (ATR)
- SRTS 0.44
- OMGA 0.09
- MACD
- SRTS -0.07
- OMGA -0.02
- Stochastic Oscillator
- SRTS 19.70
- OMGA 4.47
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.